{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T14:27:42Z","timestamp":1795184862203,"version":"4.10.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural science research plan of Huai'an","award":["HAB202135"],"award-info":[{"award-number":["HAB202135"]}]},{"name":"Natural science research plan of Huai'an","award":["HAB202319"],"award-info":[{"award-number":["HAB202319"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170757"],"award-info":[{"award-number":["82170757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Development Fund Project of Affiliated Hospital of Xuzhou Medical University","award":["XYFM202247"],"award-info":[{"award-number":["XYFM202247"]}]},{"name":"Joint Fund of the Huai'an Natural Science Foundation and the Huai'an Commission of Health","award":["HABL202242"],"award-info":[{"award-number":["HABL202242"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Mitochondrial dysfunction and abnormal energy metabolism are key determinants of the progression of acute kidney injury (AKI). \u03b1-Ketoglutarate (AKG) is an intermediate metabolite of the tricarboxylic acid cycle and plays a crucial role in energy metabolism and amino acid synthesis. However, the role of AKG in AKI therapy remains incompletely understood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Cisplatin (CIS) was employed to establish acute kidney injury models in mice and cells, with DM-AKG administered as an intervention. Network pharmacology was utilized to predict the target genes and pathway enrichment of AKG in the treatment of AKI. Apoptosis was assessed using flow cytometry, and cell viability was determined via the CCK-8 assay. The levels of intracellular reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were assessed using optical microscopy. Renal function was evaluated using absorbance spectroscopy. Hematoxylin\u2013eosin (H&amp;E) staining was used to examine the pathological changes in renal tissues across different groups. The ultrastructure of mitochondria was examined using transmission electron microscopy. Protein expression levels of KIM-1, Caspase-3, DRP1, MFN1, PINK1, and Parkin were evaluated using Western blot analysis. The expression of PINK1 and Parkin was examined by immunohistochemistry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Herein, we demonstrate that dimethyl \u03b1-ketoglutarate (DM-AKG), an AKG derivative with favorable cell membrane permeability, effectively ameliorates cisplatin (CIS)-induced AKI. Further network pharmacological analyses revealed that AKG could treat AKI through 91 potential targets of action. Moreover, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses showed significant enrichment of pathways related to mitochondria and energy metabolism. Furthermore, in a CIS-treated HK-2 cell model, we found that exogenous DM-AKG supplementation improved mitochondrial dynamics (increased expression of the mitochondrial fusion protein MFN1 and decreased expression of the mitochondrial fission protein DRP1), increased mitochondrial membrane potential, and decreased reactive oxygen species generation. Consistent with these findings, in the CIS-AKI mouse model, DM-AKG similarly improved mitochondrial morphology, structure, and dynamics, as well as increased mitophagy observed by electron microscopy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These results suggest that DM-AKG may exert a therapeutic effect on AKI by improving mitochondrial function. Regarding the molecular mechanism, we confirmed that DM-AKG could increase mitophagy and promote the clearance of damaged mitochondria by activating the PINK1\/Parkin pathway, which could play a protective role in the kidney. In conclusion, our study provides a novel strategy for the effective treatment of AKI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40001-025-03010-7","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T02:15:04Z","timestamp":1755051304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dimethyl \u03b1-ketoglutarate ameliorates cisplatin-induced acute kidney injury by modulating mitophagy through the PINK1\/Parkin pathway"],"prefix":"10.1186","volume":"30","author":[{"given":"Haijing","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangshu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"1","key":"3010_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jcm12010375","volume":"12","author":"F Turgut","year":"2023","unstructured":"Turgut F, Awad AS, Abdel-Rahman EM. Acute kidney injury: medical causes and pathogenesis. J Clin Med. 2023;12(1):11. https:\/\/doi.org\/10.3390\/jcm12010375.","journal-title":"J Clin Med"},{"issue":"3","key":"3010_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1681\/asn.2015030309","volume":"27","author":"DP Basile","year":"2016","unstructured":"Basile DP, Bonventre JV, Mehta R, Nangaku M, Unwin R, Rosner MH, et al. Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J Am Soc Nephrol. 2016;27(3):687\u201397. https:\/\/doi.org\/10.1681\/asn.2015030309.","journal-title":"J Am Soc Nephrol"},{"key":"3010_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev-physiol-021119-034658","volume":"82","author":"ME Choi","year":"2020","unstructured":"Choi ME. Autophagy in kidney disease. Annu Rev Physiol. 2020;82:297\u2013322.","journal-title":"Annu Rev Physiol"},{"issue":"24","key":"3010_CR4","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1111\/febs.17130","volume":"291","author":"RZ Huang","year":"2024","unstructured":"Huang RZ, Zhang CY, Xiang ZJ, Lin T, Ling J, Hu HL. Role of mitochondria in renal ischemia-reperfusion injury. FEBS J. 2024;291(24):5365\u201378. https:\/\/doi.org\/10.1111\/febs.17130.","journal-title":"FEBS J"},{"issue":"9","key":"3010_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/biom11091259","volume":"11","author":"AP Jim\u00e9nez-Uribe","year":"2021","unstructured":"Jim\u00e9nez-Uribe AP, Hern\u00e1ndez-Cruz EY, Ram\u00edrez-Maga\u00f1a KJ, Pedraza-Chaverri J. Involvement of tricarboxylic acid cycle metabolites in kidney diseases. Biomolecules. 2021;11(9):20. https:\/\/doi.org\/10.3390\/biom11091259.","journal-title":"Biomolecules"},{"issue":"12","key":"3010_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-024-00872-8","volume":"20","author":"MGE Knol","year":"2024","unstructured":"Knol MGE, Wulfmeyer VC, M\u00fcller RU, Rinschen MM. Amino acid metabolism in kidney health and disease. Nat Rev Nephrol. 2024;20(12):771\u201388. https:\/\/doi.org\/10.1038\/s41581-024-00872-8.","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"3010_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13(10):629\u201346. https:\/\/doi.org\/10.1038\/nrneph.2017.107.","journal-title":"Nat Rev Nephrol"},{"key":"3010_CR8","first-page":"529","volume-title":"Mitochondrial dynamics in cardiovascular medicine advances in experimental medicine and biology","author":"P Duann","year":"2017","unstructured":"Duann P, Lin PH. Mitochondria damage and kidney disease. In: Santulli G, editor. Mitochondrial dynamics in cardiovascular medicine advances in experimental medicine and biology. Cham: Springer International Publishing; 2017. p. 529\u201351."},{"issue":"2","key":"3010_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tem.2021.11.003","volume":"33","author":"B Gyanwali","year":"2022","unstructured":"Gyanwali B, Lim ZX, Soh J, Lim C, Guan SP, Goh J, et al. Alpha-ketoglutarate dietary supplementation to improve health in humans. Trends Endocrinol Metab. 2022;33(2):136\u201346. https:\/\/doi.org\/10.1016\/j.tem.2021.11.003.","journal-title":"Trends Endocrinol Metab"},{"key":"3010_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3408467","author":"SJ Liu","year":"2018","unstructured":"Liu SJ, He LQ, Yao K. The antioxidative function of alpha-ketoglutarate and its applications. Biomed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/3408467.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3010_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s10020-024-00783-1","volume":"30","author":"H Yu","year":"2024","unstructured":"Yu H, Gan DJ, Luo Z, Yang QL, An DQ, Zhang H, et al. \u03b1-Ketoglutarate improves cardiac insufficiency through NAD+-SIRT1 signaling-mediated mitophagy and ferroptosis in pressure overload-induced mice. Mol Med. 2024;30(1):14. https:\/\/doi.org\/10.1186\/s10020-024-00783-1.","journal-title":"Mol Med"},{"key":"3010_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.redox.2024.103230","volume":"74","author":"DY Cheng","year":"2024","unstructured":"Cheng DY, Zhang M, Zheng YZ, Wang M, Gao YL, Wang XD, et al. \u03b1-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1 \u03b1 \/ Nrf2 pathway. Redox Biol. 2024;74:14. https:\/\/doi.org\/10.1016\/j.redox.2024.103230.","journal-title":"Redox Biol"},{"issue":"10\u201312","key":"3010_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/ars.2022.0215","volume":"39","author":"DY Cheng","year":"2023","unstructured":"Cheng DY, Liu XY, Gao YL, Cui L, Wang M, Zheng YZ, et al. \u0391-ketoglutarate attenuates hyperlipidemia-induced endothelial damage by activating the Erk-Nrf2 signaling pathway to inhibit oxidative stress and mitochondrial dysfunction. Antioxid Redox Signal. 2023;39(10\u201312):777\u201393. https:\/\/doi.org\/10.1089\/ars.2022.0215.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"3010_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/nu15030701","volume":"15","author":"JQ Tian","year":"2023","unstructured":"Tian JQ, Bao XT, Yang F, Tang XZ, Jiang Q, Li YY, et al. Elevation of intracellular alpha-ketoglutarate levels inhibits osteoclastogenesis by suppressing the NF-\u03baB signaling pathway in a PHD1-dependent manner. Nutrients. 2023;15(3):18. https:\/\/doi.org\/10.3390\/nu15030701.","journal-title":"Nutrients"},{"issue":"1","key":"3010_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s10020-023-00733-3","volume":"29","author":"QM Gong","year":"2023","unstructured":"Gong QM, Lai TF, Liang LD, Jiang Y, Liu FH. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury. Mol Med. 2023;29(1):18. https:\/\/doi.org\/10.1186\/s10020-023-00733-3.","journal-title":"Mol Med"},{"issue":"1","key":"3010_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.7150\/ijbs.78097","volume":"19","author":"J Zhang","year":"2023","unstructured":"Zhang J, Luan ZL, Huo XK, Zhang M, Morisseau C, Sun CP, et al. Direct targeting of sEH with alisol B alleviated the apoptosis, inflammation, and oxidative stress in cisplatin-induced acute kidney injury. Int J Biol Sci. 2023;19(1):294\u2013310. https:\/\/doi.org\/10.7150\/ijbs.78097.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"3010_CR17","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1681\/asn.2017050581","volume":"29","author":"B Yang","year":"2018","unstructured":"Yang B, Lan SS, Dieud\u00e9 M, Sabo-Vatasescu JP, Karakeussian-Rimbaud A, Turgeon J, et al. Caspase-3 is a pivotal regulator of microvascular rarefaction and renal fibrosis after ischemia-reperfusion injury. J Am Soc Nephrol. 2018;29(7):1900\u201316. https:\/\/doi.org\/10.1681\/asn.2017050581.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3010_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/0886022x.2024.2365982","volume":"46","author":"Y Ji","year":"2024","unstructured":"Ji Y, Xiao YM, Li SP, Fan YH, Cai YZ, Yang B, et al. Protective effect and mechanism of Xiaoyu Xiezhuo decoction on ischemia-reperfusion induced acute kidney injury based on gut-kidney crosstalk. Ren Fail. 2024;46(2):17. https:\/\/doi.org\/10.1080\/0886022x.2024.2365982.","journal-title":"Ren Fail"},{"issue":"5","key":"3010_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41419-023-05854-5","volume":"14","author":"ZL Li","year":"2023","unstructured":"Li ZL, Ding L, Ma RX, Zhang Y, Zhang YL, Ni WJ, et al. Activation of HIF-1\u03b1 C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagy. Cell Death Dis. 2023;14(5):14. https:\/\/doi.org\/10.1038\/s41419-023-05854-5.","journal-title":"Cell Death Dis"},{"key":"3010_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.redox.2024.103340","volume":"76","author":"J Lumpuy-Castillo","year":"2024","unstructured":"Lumpuy-Castillo J, Amador-Mart\u00ednez I, D\u00edaz-Rojas M, Lorenzo O, Pedraza-Chaverri J, S\u00e1nchez-Lozada LG, et al. Role of mitochondria in reno-cardiac diseases: a study of bioenergetics, biogenesis, and GSH signaling in disease transition. Redox Biol. 2024;76:25. https:\/\/doi.org\/10.1016\/j.redox.2024.103340.","journal-title":"Redox Biol"},{"key":"3010_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119297","author":"ZZ Ai","year":"2025","unstructured":"Ai ZZ, Yuan DF, Dong RT, Zhou SS, Cao JG. Rostellularia procumbens (L) Nees. extract attenuates adriamycin-induced nephropathy by maintaining mitochondrial dynamics balance via SIRT1\/ PGC-1\u03b1 signaling pathway activation. J Ethnopharmacol. 2025. https:\/\/doi.org\/10.1016\/j.jep.2024.119297.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3010_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41467-024-45440-7","volume":"15","author":"S Ranjbarvaziri","year":"2024","unstructured":"Ranjbarvaziri S, Zeng A, Wu I, Greer-Short A, Farshidfar F, Budan A, et al. Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice. Nat Commun. 2024;15(1):17. https:\/\/doi.org\/10.1038\/s41467-024-45440-7.","journal-title":"Nat Commun"},{"issue":"1","key":"3010_CR23","doi-asserted-by":"publisher","first-page":"F56","DOI":"10.1152\/ajprenal.00070.2012","volume":"303","author":"A Bienholz","year":"2012","unstructured":"Bienholz A, Petrat F, Wenzel P, Ickerott P, Weinberg JM, Witzke O, et al. Adverse effects of \u03b1-ketoglutarate\/malate in a rat model of acute kidney injury. Am J Physiology-Renal Physiol. 2012;303(1):F56\u201363. https:\/\/doi.org\/10.1152\/ajprenal.00070.2012.","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"11","key":"3010_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms25116223","volume":"25","author":"A Strazdauskas","year":"2024","unstructured":"Strazdauskas A, Trumbeckaite S, Jakstas V, Dambrauskiene J, Mieldazyte A, Klimkaitis K, et al. In vitro hypoxia\/reoxygenation induces mitochondrial cardiolipin remodeling in human kidney cells. Int J Mol Sci. 2024;25(11):17. https:\/\/doi.org\/10.3390\/ijms25116223.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"3010_CR25","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1016\/j.celrep.2017.12.005","volume":"21","author":"B Ugur","year":"2017","unstructured":"Ugur B, Bao H, Stawarski M, Duraine LR, Zuo ZY, Lin YQ, et al. The Krebs cycle enzyme isocitrate dehydrogenase 3A couples mitochondrial metabolism to synaptic transmission. Cell Rep. 2017;21(13):3794\u2013806. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.005.","journal-title":"Cell Rep"},{"key":"3010_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.actbio.2023.11.022","volume":"173","author":"CN Cheng","year":"2024","unstructured":"Cheng CN, Xing ZY, Hu Q, Kong N, Liao CS, Xu SX, et al. A bone-targeting near-infrared luminescence nanocarrier facilitates alpha-ketoglutarate efficacy enhancement for osteoporosis therapy. Acta Biomater. 2024;173:442\u201356. https:\/\/doi.org\/10.1016\/j.actbio.2023.11.022.","journal-title":"Acta Biomater"},{"issue":"9","key":"3010_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/genes14091818","volume":"14","author":"BI Ruiz","year":"2023","unstructured":"Ruiz BI, Lowman XH, Yang Y, Fan Q, Wang TH, Wu HM, et al. Alpha-ketoglutarate regulates Tnfrsf12a\/Fn14 expression via histone modification and prevents cancer-induced cachexia. Genes. 2023;14(9):15. https:\/\/doi.org\/10.3390\/genes14091818.","journal-title":"Genes"},{"issue":"11\u201312","key":"3010_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1439-0396.2005.00566.x","volume":"89","author":"M Dabek","year":"2005","unstructured":"Dabek M, Kruszewska D, Filip R, Hotowy A, Pierzynowski L, Wojtasz-Pajak A, et al. \u03b1-ketoglutarate (AKG) absorption from pig intestine and plasma pharmacokinetics. J Anim Physiol Anim Nutr. 2005;89(11\u201312):419\u201326. https:\/\/doi.org\/10.1111\/j.1439-0396.2005.00566.x.","journal-title":"J Anim Physiol Anim Nutr"},{"issue":"7\u20138","key":"3010_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1439-0396.2002.00380.x","volume":"86","author":"NB Kristensen","year":"2002","unstructured":"Kristensen NB, Jungvid H, Fern\u00e1ndez JA, Pierzynowski SG. Absorption and metabolism of \u03b1-ketoglutarate in growing pigs. J Anim Physiol Anim Nutr. 2002;86(7\u20138):239\u201345. https:\/\/doi.org\/10.1046\/j.1439-0396.2002.00380.x.","journal-title":"J Anim Physiol Anim Nutr"},{"issue":"1","key":"3010_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00005-016-0406-x","volume":"65","author":"B Zdzisinska","year":"2017","unstructured":"Zdzisinska B, Zurek A, Kandefer-Szerszen M. Alpha-ketoglutarate as a molecule with pleiotropic activity: well-known and novel possibilities of therapeutic use. Arch Immunol Ther Exp. 2017;65(1):21\u201336. https:\/\/doi.org\/10.1007\/s00005-016-0406-x.","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"3010_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000526308","volume":"147","author":"P Singh","year":"2023","unstructured":"Singh P. Reprogramming of energy metabolism in kidney disease. Nephron. 2023;147(1):61\u20134. https:\/\/doi.org\/10.1159\/000526308.","journal-title":"Nephron"},{"issue":"5","key":"3010_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","volume":"17","author":"CY Tang","year":"2021","unstructured":"Tang CY, Cai J, Yin XM, Weinberg JM, Venkatachalam MA, Dong Z. Mitochondrial quality control in kidney injury and repair. Nat Rev Nephrol. 2021;17(5):299\u2013318. https:\/\/doi.org\/10.1038\/s41581-020-00369-0.","journal-title":"Nat Rev Nephrol"},{"key":"3010_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fphys.2023.1344271","volume":"14","author":"WB Tang","year":"2024","unstructured":"Tang WB, Wei QQ. The metabolic pathway regulation in kidney injury and repair. Front Physiol. 2024;14:12. https:\/\/doi.org\/10.3389\/fphys.2023.1344271.","journal-title":"Front Physiol"},{"key":"3010_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biopha.2024.116730","volume":"175","author":"M Katerelos","year":"2024","unstructured":"Katerelos M, Gleich K, Harley G, Loh K, Oakhill JS, Kemp BE, et al. The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury. Biomed Pharmacother. 2024;175:13. https:\/\/doi.org\/10.1016\/j.biopha.2024.116730.","journal-title":"Biomed Pharmacother"},{"key":"3010_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopha.2019.109772","volume":"122","author":"Q Ren","year":"2020","unstructured":"Ren Q, Guo F, Tao SB, Huang RS, Ma L, Fu P. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-\u03baB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother. 2020;122:9. https:\/\/doi.org\/10.1016\/j.biopha.2019.109772.","journal-title":"Biomed Pharmacother"},{"key":"3010_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2821731","author":"ZY Lin","year":"2019","unstructured":"Lin ZY, Liu ZW, Wang X, Qiu C, Zheng SX. MiR-21-3p plays a crucial role in metabolism alteration of renal tubular epithelial cells during sepsis associated acute kidney injury via AKT\/CDK2-FOXO1 pathway. BioMed Res Int. 2019. https:\/\/doi.org\/10.1155\/2019\/2821731.","journal-title":"BioMed Res Int"},{"issue":"2","key":"3010_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/biom13020226","volume":"13","author":"E Makinde","year":"2023","unstructured":"Makinde E, Ma LL, Mellick GD, Feng YJ. Mitochondrial modulators: the defender. Biomolecules. 2023;13(2):27. https:\/\/doi.org\/10.3390\/biom13020226.","journal-title":"Biomolecules"},{"key":"3010_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biocel.2015.01.022","volume":"63","author":"S Vidali","year":"2015","unstructured":"Vidali S, Aminzadeh S, Lambert B, Rutherford T, Sperl W, Kofler B, et al. Mitochondria: the ketogenic diet-a metabolism-based therapy. Int J Biochem Cell Biol. 2015;63:55\u20139. https:\/\/doi.org\/10.1016\/j.biocel.2015.01.022.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"3010_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15548627.2022.2084862","volume":"19","author":"LJ Su","year":"2023","unstructured":"Su LJ, Zhang JH, Gomez H, Kellum JA, Peng ZY. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023;19(2):401\u201314. https:\/\/doi.org\/10.1080\/15548627.2022.2084862.","journal-title":"Autophagy"},{"issue":"1\u20132","key":"3010_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1\u20132):11\u201342. https:\/\/doi.org\/10.1016\/j.cell.2018.09.048.","journal-title":"Cell"},{"key":"3010_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101767","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhu JF, Liu ZW, Shu SQ, Fu Y, Liu YX, et al. The PINK1\/PARK2\/optineurin pathway of mitophagy is activated for protection in septic acute kidney injury. Redox Biol. 2021. https:\/\/doi.org\/10.1016\/j.redox.2020.101767.","journal-title":"Redox Biol"},{"issue":"2","key":"3010_CR42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.yexcr.2016.12.015","volume":"350","author":"CY Zhao","year":"2017","unstructured":"Zhao CY, Chen ZY, Xu XG, An XF, Duan SY, Huang ZM, et al. Pink1\/Parkin-mediated mitophagy play a protective role in cisplatin induced renal tubular epithelial cells injury. Exp Cell Res. 2017;350(2):390\u20137. https:\/\/doi.org\/10.1016\/j.yexcr.2016.12.015.","journal-title":"Exp Cell Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03010-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:20:45Z","timestamp":1757452845000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03010-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3010"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03010-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experimental procedures adhered to the regulations set forth by the Experimental Animal Ethics Committee of Xuzhou Medical University (Ethics Approval Number: L20223605). Moreover, all authors strictly followed the ARRIVE guidelines throughout the experimental process to ensure the quality and transparency of the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"746"}}